JMP Securities Raises Hinge Health's Target Price to $65

institutes_icon
LongbridgeAI
08-07 23:47
1 sources

Summary

JMP Securities raised Hinge Health’s (NYSE:HNGE) price target from $58.00 to $65.00, maintaining a ‘market outperform’ rating. This suggests a potential upside of 9.37% from the current price. Other analysts have also increased their targets, with Bank of America setting it at $64.00 and Needham & Company at $59.00. Hinge Health’s stock rose 23.2% to $59.43, with a trading volume of 1,423,669 shares. The stock has an average rating of ‘buy’ and a consensus target price of $55.07.Market Beat

Impact Analysis

This event is classified at the company level as it directly pertains to Hinge Health. The increase in the price target from JMP Securities, alongside similar adjustments from other analysts, suggests a strong market confidence in Hinge Health’s future performance. The immediate effect is seen in the 23.2% rise in the stock price, reflecting heightened investor interest and positive sentiment. The raised targets signify potential investment opportunities for investors looking for growth in the healthcare technology sector, as the stock is currently trading at $59.43, close to the new targets set by analysts.Market Beat

Event Track